Cognitive Training to Improve Cognitive Function Following Chemotherapy

Cognitive Dysfunction Clinical Trial

— KT  

Official title:

Training of Cognitive Function of Patients After Chemotherapy

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT01013233
• Other study ID #: KTST09
• Status: Not yet recruiting
• Phase: N/A
• First received: November 12, 2009
• Last updated: November 12, 2009
• Start date: December 2009
• Est. completion date: October 2011

Study information

• Verified date: November 2009
• Source: Charite University, Berlin, Germany
• Contact: Susanne Effenberger, MSc
• Phone: +49-30-8445-2410
• Email: susanne.effenberger[@]charite.de
• Is FDA regulated: No
• Health authority: Germany: Ethics Commission
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to improve cognitive dysfunction following chemotherapy, the investigators investigated to see whether a cognitive training for memory and concentration skills can improve cognitive performance in patients following cancer treatment.

Description:

Patients following chemotherapy invited for a cognitive training. Before and after cognitive function will evaluate.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 20
• Est. completion date: October 2011
• Est. primary completion date: October 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• patients with cancer 6 weeks after chemotherapy

Exclusion Criteria:

• patients with neurological or psychiatric disorders

• patients without compliance

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Cognition Disorders
• Cognitive Dysfunction

Intervention

Behavioral:
• cognitive training
cognitive training over 6 weeks, consist of 6 meetings (a 45minutes), three sessions focus on concentration tasks and three sessions on memory problems.

Other:
• control group
no intervention

Locations

Country	Name	City	State
Germany	Charite Universitätsmedizin Berlin	Berlin

Sponsors (2)

Lead Sponsor	Collaborator
Charite University, Berlin, Germany	Freie Universität Berlin

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	several cognitive tests (TAP, VLMT, TMT, Stroop, RWT, D2, LGT-3)		one weeks following the end of the cognitive training	No
Secondary	quality of life and subjective perception of cognitive problems		7 weeks	No